A pioneering gene therapy company has selected ValGenesis VLMS for its remote validation capability, and for its ability to enable efficient change and risk management to help the company achieve better control over these processes.
The scalable and configurable nature of ValGenesis VLMS will enable Biocon Biologics’ quality leaders to monitor the validation status of their instruments, equipment, software systems, and processes remotely and in real time across multiple sites.
ValGenesis VLMS enables remote validation execution, preventing interruptions in the company’s validation programs especially in these times when their workforce is predominantly remote and/or working from home. The system is configurable and scalable to facilitate implementation at a single site and expansion across multiple sites in the future.
A global Top 5 life science organization has chosen ValGenesis VLMS for its depth of functionality and ability to meet all the company’s business needs. ValGenesis will manage the validation of the company’s Labs with initial deployment across two sites.
ValGenesis VLMS will help the company achieve more efficient change control management across their IT Business systems, and enable control and flexibility in assigning and managing the various validation activities.
A Top10 US-based injectable company selects ValGenesis VLMS – a single, end-to-end, digital validation solution that can enable a single source of truth, thereby ensuring data integrity and adherence to all regulatory requirements.
ValGenesis VLMS, a 100% paperless validation lifecycle management system, incorporates electronic document and process workflows, electronic signatures, with requirements tracking and test protocol integration which helps accelerate the validation process while guaranteeing an integrated approach to risk, thereby enabling stringent data integrity governance and regulatory compliance.
By automating their corporate validation process, ValGenesis VLMS has enabled significant efficiency gains, including a reduction in the validation cycle time, enabling data integrity governance, improving regulatory compliance, and providing a holistic view of real-time validation status of GxP systems and processes across the agency.